Insider Trading Activity For Eli Lilly and Company (NYSE:LLY)
Lilly Endowment Inc , Major Shareholder of Eli Lilly and Company (NYSE:LLY) reportedly Sold 220,000 shares of the company’s stock at an average price of 83.09 for a total transaction amount of $18,279,800.00 SEC Form
Insider Trading History For Eli Lilly and Company (NYSE:LLY)
On 3/26/2013 Susan Mahony, SVP, sold 5,000 with an average share price of $56.00 per share and the total transaction amounting to $280,000.00.View SEC Filing
On 5/10/2013 Jeffrey N Simmons, SVP, sold 10,000 with an average share price of $54.49 per share and the total transaction amounting to $544,900.00.View SEC Filing
On 5/15/2013 Enrique A Conterno, VP, sold 5,000 with an average share price of $56.15 per share and the total transaction amounting to $280,750.00.View SEC Filing
On 6/17/2013 Enrique A Conterno, VP, sold 5,000 with an average share price of $52.45 per share and the total transaction amounting to $262,250.00.View SEC Filing
On 7/15/2013 Enrique A Conterno, VP, sold 5,000 with an average share price of $51.43 per share and the total transaction amounting to $257,150.00.View SEC Filing
On 7/29/2013 Jacques Tapiero, SVP, sold 7,500 with an average share price of $53.74 per share and the total transaction amounting to $403,050.00.View SEC Filing
On 8/15/2013 Enrique Conterno, VP, sold 5,000 with an average share price of $53.79 per share and the total transaction amounting to $268,950.00.View SEC Filing
Analyst Ratings For Eli Lilly and Company (NYSE:LLY)
These are 1 Sell Rating, 6 Hold Ratings, 11 Buy Ratings .
The current consensus rating for Eli Lilly and Company (NYSE:LLY) is Buy (Score: 2.56) with a consensus target price of $89.29 , a potential (8.41% upside)
Analyst Ratings History For Eli Lilly and Company (NYSE:LLY)
- On 12/22/2015 Bank of America Corp Reiterated Rating Buy with a price target of $104.00 to $108.00
- On 6/15/2016 SunTrust Banks, Inc. Reiterated Rating Buy
- On 10/27/2016 Societe Generale Reiterated Rating Hold with a price target of $78.00
- On 11/25/2016 Atlantic Securities Downgraded rating Overweight to Neutral
- On 11/26/2016 J P Morgan Chase & Co Reiterated Rating Overweight
- On 4/17/2017 Morgan Stanley Downgraded rating Overweight to Equal Weight with a price target of $82.00
- On 4/17/2017 Cowen and Company Boost Price Target of rating Outperform with a price target of $85.00 to $95.00
Dividend Information For Eli Lilly and Company (NYSE:LLY)
Eli Lilly and Company (NYSE:LLY) pays an annual dividend of Community Ranking: with a yield of 2.53% and an average dividend growth of 1.30% (3 Year Average).
Dividend History For Eli Lilly and Company (NYSE:LLY)
On 12/17/2012 Eli Lilly and Company announced a quarterly dividend of $0.49 3.96% with an ex dividend date of 2/13/2013 which will be payable on 3/8/2013.
On 5/6/2013 Eli Lilly and Company announced a quarterly dividend of $0.49 3.62% with an ex dividend date of 5/14/2013 which will be payable on 6/10/2013.
On 6/18/2013 Eli Lilly and Company announced a quarterly dividend of $0.49 3.82% with an ex dividend date of 8/13/2013 which will be payable on 9/10/2013.
On 10/21/2013 Eli Lilly and Company announced a quarterly dividend of $0.49 3.91% with an ex dividend date of 11/13/2013 which will be payable on 12/10/2013.
On 12/16/2013 Eli Lilly and Company announced a quarterly dividend of $0.49 3.98% with an ex dividend date of 2/12/2014 which will be payable on 3/10/2014.
On 5/5/2014 Eli Lilly and Company announced a quarterly dividend of $0.49 3.35% with an ex dividend date of 5/13/2014 which will be payable on 6/10/2014.
On 6/16/2014 Eli Lilly and Company announced a quarterly dividend of $0.49 3.31% with an ex dividend date of 8/13/2014 which will be payable on 9/10/2014.
Recent Trading Activity for Eli Lilly and Company (NYSE:LLY)
Shares of Eli Lilly and Company closed the previous trading session at 82.37 down -0.29 -0.35% with 4,082,999 shares trading hands.